• Skip to primary navigation
  • Skip to main content
  • Skip to footer
MotherToBaby

MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

Hide Search
Shopping Cart
Show SearchSearch
866.626.6847
  • About
    • Our Work
    • Our Team
    • About OTIS
    • In Your Area
    • Our Partners
    • Our Impact
  • Exposures
    • Pregnancy and Breastfeeding Exposures
    • Fact Sheets
    • Baby Blogs
    • Podcasts
    • Interactive Tool
    • Other Educational Tools
    • LactRx App
  • Studies
    • Ongoing Studies
    • What’s Involved?
    • Join Now
    • Refer a Patient
    • Health Providers
    • Pharma Industry
    • Publications
  • Health Professionals
    • Patient Education and Provider Resources
    • Refer a Patient
    • Request Materials
    • Annual Meeting
    • Exhibiting Schedule
    • FAQs
    • OTIS Membership
  • Media
    • Media Requests
    • Press Releases
    • eNews Sign Up
  • Donate
  • Contact
  • Show SearchSearch

Fluphenazine (Prolixin®, Permitil®)

March 1, 2024

Selected References:

  • Aleem M, et al. 2005. Hyperprolactinemia affects spermiogenesis in adult male rats. Journal of Endocrinological Investigation 28(1):39-48.
  • Auerbach JG, et al. 1992. Maternal psychotropic medication and neonatal behavior. Neurotoxicol Teratol 14(6):399-406.
  • Cleary MF. 1977. Fluphenazine decanoate during pregnancy. Am J Psychiat 134:815-816.
  • Donaldson GL, Bury RG. 1982. Multiple congenital abnormalities in a newborn boy associated with maternal use of fluphenazine enanthate and other drugs during pregnancy. Acta Paediatr Scand 71:335-338.
  • Einarson A, Boskovic R. 2009. Use and safety of antipsychotic drugs during pregnancy. J Psychiatr Pract 15(3):183-192.
  • 2011. Drug Safety Communication: Antipsychotic drug labels updated on use during pregnancy and risk of abnormal muscle movements and withdrawal symptoms in newborns (issued 2/2011). https://www.fda.gov/Drugs/DrugSafety/ucm243903.htm
  • 2018. Retrieved from https://toxnet.nlm.nih.gov/cgi-bin/sis/search2
  • Gill-Sharma MK, et al. 2003. Antifertility effects of fluphenazine in adult male rats. Journal of Endocrinological Investigation 26(4):316-326.
  • Gomez EA. 1981. Hypersexuality in men receiving fluphenazine decanoate (letter). Am J Psychiatry 138:1263.
  • Holt RI, Peveler RC. 2011. Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management. Clin Endocrinol (Oxf) 74(2):141-147.
  • King JT, et al. 1963.Perinatal findings in women treated during pregnancy with oral fluphenazine. J New Drugs ;3:21-5
  • Kopf GS, Vacquier VD. 2011. Characterization of a calmodulin-stimulated adenylate cyclase from abalone spermatozoa. J Biol Chem 259:7590-7596.
  • Maguire GA. 2002. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences. J Clin Psychiatry 63(suppl 4):56-62.
  • Martinez JE, Wertelecki W. 1999. Schizophrenia and fluphenazine teratogenicity. Teratology 59:398.
  • Merlob P, et al. 1994. Is fluphenazine a teratogen? Am J Med Genet 52:231-232.
  • Mogwitz S, et al. 2018. Update on the Pharmacological Treatment of Tics with Dopamine-Modulating Agents. ACS Chem Neurosci 9(4):651-672.
  • Nath SP, et al. 1996. Severe rhinorrhea and respiratory distress in a neonate exposed to fluphenazine hydrochloride prenatally. Ann Pharmacotherapy 30:35-37.
  • Rumeau-Rouquette C, et al. 1977. Possible teratogenic effect of phenothiazines in human beings. Teratology15:57-64.
  • Serres C, Kahn ML. 1984. Motility induction in hamster spermatozoa from caput epididymis: effect of forward motility protein (FMP) and calmodulin inhibitor. Reprod Nutr Dev 24:81-94.
  • Siragusa S, et al. 2022. Fluphenazine. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing;. https://www.ncbi.nlm.nih.gov/books/NBK459194/.

Footer

               

Hot Links

  • Home
  • Exposures
  • Fact Sheets
  • Baby Blogs
  • Podcasts
  • Pregnancy Studies
  • Join a Study Now
  • Healthcare Professionals
  • Refer a Patient
  • Request Materials
  • News
  • Donate
  • Ask An Expert

Current Studies

  • Ankylosing Spondylitis
  • Constipation
  • Coronavirus (COVID-19)
  • Eczema (Moderate-to-Severe)/Atopic Dermatitis
  • Hidradenitis Suppurativa
  • Lupus
  • Multiple Sclerosis
  • Non-Radiographic Axial Spondyloarthritis
  • Psoriasis
  • Psoriatic Arthritis

Contact

Exposure Information Service
866.626.6847

Pregnancy Studies
877.311.8972

Media Inquiries
619.368.3259
nchavez@mothertobaby.org

MotherToBaby, a service of the Organization of Teratology Information Specialists

Copyright © 2025 The Organization of Teratology Information Specialists

  • Accessibility
  • Privacy
  • Terms
  • Site Map
^

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.